Trade secretary Cristina Aldeguer-Roque recently drew flak for her remarks on a P500 Noche Buena budget, but she did not make any statement on weekly allowancesTrade secretary Cristina Aldeguer-Roque recently drew flak for her remarks on a P500 Noche Buena budget, but she did not make any statement on weekly allowances

FACT CHECK: DTI quote on P50 weekly allowance for college students is fake

2025/12/15 15:00
4 min read
For feedback or concerns regarding this content, please contact us at [email protected]

Claim: Department of Trade and Industry (DTI) Secretary Maria Cristina Aldeguer-Roque said that a P50 allowance is sufficient for college students’ weekly expenses.

Rating: FALSE

Why we fact-checked this: The graphic began circulating on December 11 via Facebook. It featured a photo of Roque being interviewed, with text at the bottom that reads: “DTI: 50 pesos na allowance sa mga college students, kasya na for 1 week.”

(DTI: A P50 weekly allowance is enough for college students.) 

The post quickly gained traction, prompting negative reactions through reels and lengthy commentaries from social media users. Several referenced the DTI’s earlier claim that P500 would be enough for a family to have a decent Noche Buena, drawing flak from the public.

One such post received over 99,000 reactions, 20,000 comments, and 27,000 shares as of writing.

The facts: There is no record of the trade secretary making this statement in recent press events, interviews, or on official pages and websites. 

Additionally, based on a Google reverse image search, the photo used in the graphic matches photos and videos from Roque’s visit to Cebu City last November to monitor compliance with the nationwide price freeze on basic necessities. She did not make a comment about college students’ allowances at any point during this visit.

The fake quote seemed to have been intended as satire. It was originally published on December 11, drawing more than 74,000 reactions and 107,000 shares, and was accompanied by quotes implied to be Roque’s: “Choosy pa kayo! P20 nga lang sa panahon namin (You are all choosy! It was only P20 during our time).”

The creator of the graphic included a disclaimer stating that the post was satire and not intended to mislead or spread disinformation. This disclaimer, however, has been omitted in many reposts and in posts criticizing the fabricated quote. (READ: SATIRE VS FAKE NEWS: Can you tell the difference?)

DTI’s recent remarks: Prior to the circulation of the fake quote, many social media users linked it to remarks made by Roque in late November, in which she said that a budget of P500 is enough to prepare a Noche Buena meal for a family of four based on the DTI’s Price Guide.

“Kung tutuusin, sa P500 makakabili na kayo ng ham. Makakagawa ka na ng macaroni salad, makakagawa ka na rin ng spaghetti, depende rin po ’yan kung ilan ’yong taong kakain,” she said.

(If you think about it, with P500 you can already buy ham. You can make macaroni salad and spaghetti. It also depends on how many people will be eating.)

Her comments sparked strong reactions from lawmakers who called the suggestion unrealistic and tone-deaf. Vice President Sara Duterte also slammed the remark, while celebrities and social media users challenged the DTI to attempt grocery shopping with the P500 budget. (READ: [Vantage Point] The P500 Noche Buena: Rewriting math, economics, and the laws of physics)

Roque has since defended her position and clarified that the estimated budget was possible for a simple family meal for four rather than an elaborate celebration. (READ: [OPINION] Noche Buena for P500: The Christmas script no one believes anymore)

Malacañang also stood by the department, framing the discussion as a question of whether such a budget was “doable.” – Cyril Bocar/Rappler.com 

Efren Cyril Bocar is a journalist from Llorente, Eastern Samar who graduated with a degree in English Language Studies at the Visayas State University. Cyril is also a graduate of the Aries Rufo Journalism Fellowship of Rappler for 2024. 

Keep us aware of suspicious Facebook pages, groups, accounts, websites, articles, or photos in your network by contacting us at [email protected]. Let us battle disinformation one Fact Check at a time.

Market Opportunity
Factor Logo
Factor Price(FACT)
$0.59
$0.59$0.59
-4.83%
USD
Factor (FACT) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09